Truist Securities Reiterates Buy on CG Oncology, Raises Price Target to $100

Benzinga · 1d ago
Truist Securities analyst Gregory Renza reiterates CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $85 to $100.